Malaysian well being authorities on Monday mentioned the vaccine developed by AstraZeneca is protected for use, three days after the Southeast Asian nation obtained its first batch of the photographs purchased by the worldwide COVAX facility.
Some international locations have restricted or halted its use over potential hyperlinks to blood clotting. AstraZeneca says regulatory opinions in Britain and Europe have famous its vaccine affords a excessive degree of safety and that its advantages far outweigh any dangers
“I verify the vaccine developed by AstraZeneca is protected, and it is going to be administered to these aged 60 years and older,” Health Minister Adham Baba said in a televised news conference.
Malaysia received its first shipment of nearly 270,000 doses of AstraZeneca’s vaccine on Friday.
Ministry officials said the vaccine was found to be “suitable for use” for these aged 60 and older, and we’re trying into the out there information earlier than approving it for use for different age teams.
Malaysia secured a complete of 12.8 million doses from AstraZeneca, half of which is able to come by way of the COVAX facility. It was slated to obtain the primary 600,000 doses in June.
Read all of the Latest News and Breaking News right here
